Categories for News

Barts Life Sciences features in the UK Science Park Association’s magazine

The UK Science Park Association (UKSPA) is a not-for-profit Membership organisation representing Science Parks and innovation locations across the UK. Their Members span Science Park owners, investors and developers, as well as supporting professional service firms. UKSPA Members are linked to strategic innovation sectors for the UK, including Life Sciences. UKSPA’s purpose is to share best practice amongst their Members...

Unlocking innovation from within the University base: How Queen Mary University of London is embedding innovation into the research culture

Queen Mary Innovation (QMI) is dedicated to maximising the economic and social impact of Queen Mary’s research using commercial tools. They protect and license intellectual property while building sustainable enterprises and social ventures to bring Queen Mary’s cutting-edge research to a global audience. QMI currently has a portfolio of nearly 30 companies across diverse industries. They create three new spinouts...

Barts Life Sciences, Barts Health NHS Trust and Capital City College Group partner to establish a new Health and Life Sciences Skills and Training Hub

Barts Health NHS Trust and Barts Life Sciences have joined forces with Capital City College Group (CCCG) to establish Barts Health Futures, a pioneering Health and Life Sciences Skills Hub. The partnership, marked by a signing ceremony at CCCG’s Angel centre, will offer diverse education and qualification pathways to students across London, equipping them with essential skills for the healthcare...

Ground-breaking AI innovation for emergency care assessment

A pioneering AI technology designed to speed up patient care through improved assessment in the emergency department is currently being trialled at the Royal London Hospital (RLH) as part of a groundbreaking collaboration between Bingli, Barts Health and Barts Life Sciences (BLS). Emergency Departments (ED) are under significant pressure, with the four-hour wait time target consistently missed. BLS is at...

Putting East London at the forefront of clinical research

Clinical trials are important for helping to improve health outcomes for our community.  A Clinical Research Facility (CRF) is both a physical place and importantly a team of skilled healthcare professionals who help to deliver research studies.  Barts Health is a highly research-active organisation, and last year recruited more people into clinical trials than ever before. Next year, we will...

Revolutionising Health Outcomes: The Impact of Barts Life Sciences on Precision Medicine and Global Health

The healthcare research landscape has advanced dramatically in the past decade. Breakthroughs in areas such as genomics now enable us to diagnose and treat diseases with unprecedented precision. In this blog post, we spoke with Professor Sir Mark Caulfield, Vice Principal for Health Queen Mary University of London, Faculty of Medicine and Dentistry and Director of the NIHR Barts Biomedical...

UK Life Science Clusters and the benefits of an East London Super Cluster

UK Science Parks and Innovation Districts have long been pivotal engines of economic growth, driving technological innovation, economic development, and enhancing global competitiveness. In this blog, Dr. Grant Bourhill, MD at Barts Life Sciences and Board Director of the UK Science Park Association, explores the evolution of these clusters over the past few decades and the anticipated benefits of the...

Finding Heart Disease Before it Finds You – A Data Science Opportunity

A project using Artificial Intelligence to tackle cardiovascular healthcare inequalities in North East London has been awarded over £300,000 by Barts Charity. The PREDICT project will use patient data to predict and prevent emergency admissions to hospital for patients with heart valve disease.    The 3-year project will translate medical notes into structured data which is suitable for identifying groups...

Using data to speed up diagnosis of rare diseases

In a new collaboration with Barts Health’s Clinical Haematology team and Sanofi, Barts Life Sciences (BLS) aims to speed up diagnosis – and in turn treatment – of rare diseases. Rare diseases aren’t as rare as you might think. In fact, 1 in 17 people in Europe will be diagnosed with one. But despite being more common than originally imagined,...

How AI is Safeguarding Patient Care at Barts Health NHS Trust

Imagine a patient, whether just starting on a diagnostic pathway or already diagnosed with a chronic condition, missing a crucial procedure or follow-up appointment – the consequences can be significant, potentially leading to a delayed diagnosis or compromised care. Barts Life Sciences, in collaboration with Barts Health’s Business Intelligence Unit, has launched the TREAT project employing Natural Language Processing (NLP)...